CG
NEOS

Cutler Group’s Neos Therapeutics, Inc NEOS Stock Holding History

Cutler Group’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-979
Closed -$4K – 4887
2018
Q3 		$4K Sell
979
-600
-38% -$3.4K ﹤0.01% 3250
2018
Q2 		$9K Buy
1,579
+100
+7% +$745 ﹤0.01% 2774
2018
Q1 		$12K Sell
1,479
-1,500
-50% -$14.3K ﹤0.01% 2692
2017
Q4 		$30K Buy
2,979
+2,479
+496% +$23.8K ﹤0.01% 2249
2017
Q3 		$4K Sell
500
-100
-17% -$760 ﹤0.01% 4683
2017
Q2 		$4K Buy
+600
New +$4.53K ﹤0.01% 5136

Other funds holding NEOS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cutler Group's NEOS Position: Q4 2018 in Review

Cutler Group sold out of Neos Therapeutics, Inc (NEOS) in Q4 2018, closing a stake of 979 shares — an estimated $4K sold.

Cutler Group first reported a position in NEOS in Q2 2017 and held it in 6 quarters. The position peaked at $30K in Q4 2017. 63 funds tracked by Wall St. Rank hold NEOS as of Q4 2018.

  • Cutler Group reported no remaining Neos Therapeutics, Inc position as of Q4 2018 after selling out during the quarter.
  • Cutler Group sold 979 Neos Therapeutics, Inc shares in Q4 2018, an estimated $4K.
  • Cutler Group first reported a position in Neos Therapeutics, Inc in Q2 2017 and held it in 6 quarters.
  • Cutler Group's Neos Therapeutics, Inc position peaked at $30K in Q4 2017.
  • 63 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2018.

Based on Cutler Group's 13F filing for Q4 2018, filed 5 Feb 2019.